[Follow-up examinations of epileptic children who interrupted treatment of their own volition].
D000367:Age Factors; D000927:Anticonvulsants / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004357:Drug Synergism; D004569:Electroencephalography; D004827:Epilepsy / Q000188:drug therapy* / Q000209:etiology; D005500:Follow-Up Studies; D006801:Humans; D006827:Hydantoins / Q000627:therapeutic use; D007223:Infant; D010113:Oxyphenbutazone / Q000627:therapeutic use; D010634:Phenobarbital / Q000627:therapeutic use; D011324:Primidone / Q000627:therapeutic use; D011379:Prognosis; D013997:Time Factors
D000927:Anticonvulsants; D006827:Hydantoins; D011324:Primidone; D010113:Oxyphenbutazone; D010634:Phenobarbital
Badania katamnestyczne dzieci z napadami padaczkowymi, u których samowolnie przerwano leczenie.